Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Okyo Pharma Limited (OKYO.LN)

Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
Help
Go To:
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 34,835
  • Shares Outstanding, K 1,415,040
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,950 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.400 unch
on 05/19/23
2.715 -48.43%
on 05/09/23
-0.150 (-9.68%)
since 04/19/23
3-Month
1.350 +3.70%
on 04/12/23
6.000 -76.67%
on 02/20/23
-4.000 (-74.07%)
since 02/17/23
52-Week
1.350 +3.70%
on 04/12/23
8.500 -83.53%
on 02/17/23
-3.100 (-68.89%)
since 05/19/22

Most Recent Stories

More News
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments FinancialNewsMedia - Tue May 2, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

ALDX : 1.5500 (-2.52%)
OKYO : 1.4900 (-2.93%)
EYPT : 13.89 (+8.26%)
NVS : 156.33 (+1.37%)
OKYO.LN : 1.400 (-24.32%)
OCUL : 9.19 (+5.15%)
Wall Street - NYSE Stock Market American Flag
Stocks Climb Before the Open as Investors Weigh Economic Outlook, U.S. JOLTs Report in Focus Barchart - Tue Apr 4, 2023

June S&P 500 futures (ESM23) are up +0.29%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.61% this morning after three major U.S. benchmark indices finished the regular session mixed as weaker-than-expected...

VORB : 0.0769 (-34.83%)
ESM23 : 4,453.35s (+0.61%)
TSLA : 328.58 (+2.83%)
ONCT : 0.5266 (-24.11%)
AMC : 2.59 (+0.78%)
NQM23 : 15,316.61s (+0.85%)
HLN : 10.03 (unch)
CRBG : 33.68 (-0.97%)
OKYO.LN : 1.400 (-24.32%)
BFLY : 8.83 (+6.39%)
EVO : 2.00 (+2.56%)
OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm Business Wire - Tue Aug 30, 2022

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, plans a Q4 2022...

OKYO : 1.4900 (-2.93%)
OKYO.LN : 1.400 (-24.32%)
More news for this symbol

Barchart Technical Opinion

Strong sell

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 2.358
2nd Resistance Point 2.167
1st Resistance Point 1.783
Last Price 1.400
1st Support Level 1.208
2nd Support Level 1.017
3rd Support Level 0.633

See More

52-Week High 8.500
Fibonacci 61.8% 5.769
Fibonacci 50% 4.925
Fibonacci 38.2% 4.081
Last Price 1.400
52-Week Low 1.350

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.